Cell Signaling Technology

Product Pathways - Growth Factors/Cytokines

Human Interleukin-3 (hIL-3) #8918

Request pricing for multi-milligram amounts.

Source

Recombinant human interleukin-3 (hIL-3) Ala20-Phe152 (Accession # NP_000579) was expressed in human 293 cells at Cell Signaling Technology.

Molecular Characterization

Recombinant hIL-3 contains no "tags" and the nonglycosylated protein has a calculated MW of 15,091. DTT-reduced and non-reduced protein migrate as 26 kDa polypeptides. Lower mobility and heterogeneity in SDS PAGE are due to glycosylation. The expected amino-terminal APMTQ of recombinant hIL-3 was verified by amino acid sequencing.

Purity

>98% as determined by SDS-PAGE of 6 μg reduced (+) and non-reduced (-) recombinant hIL-3. All lots are greater than 98% pure.

Bioactivity

The bioactivity of recombinant hIL-3 was determined in a TF-1 cell proliferation assay. The ED50 of each lot is between 50 -400 pg/ml.

Coomassie Gel

Coomassie Gel

The purity of recombinant hIL-3 was determined by SDS-PAGE of 6 µg reduced (+) and non-reduced (-) recombinant hIL-3 and staining overnight with Coomassie Blue.

Bioactivity

Bioactivity

The proliferation of TF-1 cells treated with increasing concentrations of hIL-3 was assessed. After 48 hour treatment with hIL-3, cells were incubated with a tetrazolium salt and the OD450 - OD650 was determined.

Western Blotting

Western Blotting

Western blot analysis of extracts from TF-1 cells untreated or treated with hIL-3 for 15 minutes, using Phospho-Stat5 (Tyr694) (C11C5) Rabbit mAb #9359 (upper) and Stat5 (3H7) Rabbit mAb #9358 (lower).


Endotoxin

Less than 0.01 ng endotoxin/1 μg hIL-3.

Formulation

With carrier: Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.2 containing 20 μg BSA per 1 μg hIL-3. Carrier free: Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.2.

Background

IL-3 is produced by T cells, mast cells and eosinophils (1). Target cells include hematopoietic progenitors, neutrophils, macrophages, mast cells, eosinophils, lymphoid and erythroid cells (1). The IL-3 receptor is a heterodimer of the IL-3 specific α-chain and the common β-chain, βc, which is also used by GM-CSF and IL-5. (1). Binding of IL-3 can also involve substitution of the βc by a βIL-3-chain that appears to be specific for IL-3 (1,2). Binding of IL-3 to its cognate receptor(s) induces activation of Jak2, phosphorylation of multiple Stats (1,3,5,6), and the PI3K/Akt pathway (1). IL-3 may play an important role in the development of airway inflammation associated with asthma (3,4,5).

  1. Reddy, E.P. et al. (2000) Oncogene 19, 2532-47.
  2. Hara, T. and Miyajima, A. (1992) EMBO J 11, 1875-84.
  3. Asquith, K.L. et al. (2008) J Immunol 180, 1199-206.
  4. Schroeder, J.T. et al. (2009) J Immunol 182, 2432-8.
  5. Munitz, A. et al. (2006) J Immunol 177, 77-83.

Application References

Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!

Companion Products


For Research Use Only. Not For Use In Diagnostic Procedures.

Products